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Adipocytes are a major component of the bone marrow that can critically affect meta-
static progression in bone. Understanding how the marrow fat cells influence growth, 
behavior, and survival of tumor cells requires utilization of in vitro cell systems that can 
closely mimic the physiological microenvironment. Herein, we present two new three- 
dimensional (3D) culture approaches to study adipocyte–tumor cell interactions in vitro. 
The first is a transwell-based system composed of the marrow-derived adipocytes in 
3D collagen I gels and reconstituted basement membrane-overlayed prostate tumor cell 
spheroids. Tumor cells cultured under these 3D conditions are continuously exposed 
to adipocyte-derived factors, and their response can be evaluated by morphological 
and immunohistochemical analyses. We show via immunofluorescence analysis of
metabolism-associated proteins that under 3D conditions tumor cells have significantly 
different metabolic response to adipocytes than tumor cells grown in 2D culture. We 
also demonstrate that this model allows for incorporation of other cell types, such as 
bone marrow macrophages, and utilization of dye-quenched collagen substrates for 
examination of proteolysis-driven responses to adipocyte- and macrophage-derived 
factors. Our second 3D culture system is designed to study tumor cell invasion toward 
the adipocytes and the consequent interaction between the two cell types. In this model, 
marrow adipocytes are separated from the fluorescently labeled tumor cells by a layer of 
collagen I. At designated time points, adipocytes are stained with BODIPY and confocal 
z-stacks are taken through the depth of the entire culture to determine the distance 
traveled between the two cell types over time. We demonstrate that this system can be 
utilized to study effects of candidate factors on tumor invasion toward the adipocytes. 
We also show that immunohistochemical analyses can be performed to evaluate the 
impact of direct interaction of prostate tumor cells with adipocytes. Our models under-
line the importance of using the appropriate culture conditions to mimic physiological 
interactions between marrow adipocytes and metastatic tumor cells. These systems 
have a potential to be utilized for analyses of various factors that may be regulated by the 
adipocytes in bone. Their application likely extends beyond metastatic prostate cancer 
to other tumors that colonize the bone marrow microenvironment.
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INtRodUCtIoN
Adipocytes constitute a significant portion of adult bone 
marrow and their number increases with age, obesity, and 
metabolic dysfunction (1–3). Growing evidence positively 
links the abundance of fat cells in the marrow with metastatic 
progression. Adipocyte-rich bone marrow appears to contribute 
to skeletal colonization and growth in a number of secondary 
cancers, including prostate (4, 5), breast (6), multiple myeloma 
(7, 8), and melanoma tumors (9). It is believed that adipocytes 
enhance the fertility of the bone metastatic niche by serving 
as a source of growth factors, chemokines, and lipid mediators 
(10, 11). Specifically, they have been shown to (1) upregulate 
lipid transporters and drive lipid uptake by tumor cells (5), (2) 
promote osteoclast differentiation and maturation (4, 9), and 
(3) induce authophagy-driven tumor cell survival, all processes 
that ultimately allow the metastatic cancers to thrive in the bone 
marrow niche (8). Despite these emerging data clearly pointing 
to marrow fat cells as one of the critical determinants of tumor 
cell fate in bone, their functional contribution to the growth 
and aggressiveness of metastatic tumors in bone is not well 
understood. Studies investigating the interactions between the 
tumor cells and adipocytes in the bone marrow have been limited 
and thorough mechanistic evaluations on how fat cells affect the 
phenotype, metabolism, and function of the surrounding cells 
in the metastatic niche are lacking.
The majority of the studies examining adipocyte–tumor cell 
interactions to date have utilized pre-adipocyte cell lines or adi-
pocytes derived from visceral or breast adipose tissues (12–16) 
depots, which are known to be distinctively different from bone 
marrow fat (17). There have only been a handful of studies, 
including our own, that have examined the interactions of bone 
marrow mesenchymal cell-derived or primary bone adipocytes 
with metastatic tumor cells (4, 5, 7–9). Although all of these 
investigations resulted in important findings linking marrow 
adipocytes with metastatic progression, the caveat is that they 
have all been performed using two-dimensional (2D) culture 
approaches. It is becoming increasingly recognized that 2D 
layer cultures, although convenient and reasonably inexpensive, 
do not adequately mimic the limited diffusion-driven access 
to nutrients, growth factors, and signaling molecules in the 
tumor microenvironment (18). Under physiological conditions, 
exposure of solid tumors to microenvironmental factors, such as 
oxygen, nutrients, stress, and therapeutic treatments, is hetero-
geneous and regulated by their three-dimensional (3D) spatial 
conformation (19). The importance of employing 3D models to 
model tumor architecture has proven critical to understanding 
the mechanisms behind tumor phenotype, behavior, and response 
to therapy (19–22). Emphasis has also grown on considering 
the contribution of host cells in the tumor microenvironment 
to cancer progression, and various in  vitro models that focus 
on stromal–epithelial interactions and immune cell involvement 
have emerged (21, 23–27).
Three-dimensional, multi-cellular cell culture models have 
become well-accepted tools for dissecting complex molecular 
mechanisms of tumor progression that may not be possible to 
dissect in vivo. There have also been many advancements in the 
development of 3D culture systems that mimic specific tumor 
niches, including very complex and dynamic microenvironments 
such as bone (28). Models intended to interrogate the mecha-
nisms of skeletal metastases range from culture of tumor cells and 
specific bone-derived cells on biologically derived or synthetic 
matrices, through the use of patient-derived xenografts and direct 
culture of tumor cells with bone explants (21, 28). However, aside 
from one recently reported in vitro system designed to evaluate 
bone marrow adipose colonization by breast cancer cells (6), 
there have been no in vitro 3D models that consider involvement 
of marrow adipocytes.
Here, we describe new in vitro approaches designed to study 
the interaction of prostate cancer cells with bone marrow-derived 
adipocytes. Our methods employ murine bone marrow mesen-
chymal cells differentiated into adipocytes in 3D collagen I gel 
and grown in a Transwell system with 3D-cultures of prostate 
carcinoma cells. We show that in this system, which allows con-
tinuous exchange of factors between the two cell types, adipocytes 
promote 3D growth of tumor spheroids. We also demonstrate that 
the cell culture approaches we are employing in this model allow 
for easy manipulation and are suitable for imunocytochemical 
analyses. We show examples of immunofluorescence analyses 
of metabolism-associated factors, such as carbonic anhydrase 9 
(CA9) and hexokinase 2 (HK2) that reveal distinctively differ-
ent expression profiles between 2D and 3D cultures exposed to 
adipocytes. We also demonstrate the suitability of our model to 
study proteolysis by live prostate carcinoma cells and potentially 
other components of bone marrow microenvironment, such as 
bone marrow macrophages. Finally, we also describe a design of 
a 3D invasion assay that allows direct monitoring of the attraction 
of prostate tumor cells to marrow adipocytes and can be utilized 
to evaluate potential inhibitors that target this interaction. 
Our models provide new approaches to dissect the functional 
role of marrow-derived adipocytes in tumor cell growth and 
aggressiveness.
MAteRIALs ANd Methods
Materials
Dulbecco’s modified Eagle’s medium (DMEM), minimum 
essential medium (MEMα), and other chemicals, unless other-
wise stated, were obtained from Sigma (St. Louis, MO, USA). 
HyClone fetal bovine serum (FBS) was from ThermoFisher 
(Pittsburg, PA, USA). Trypsin–EDTA, Alexa Fluor 488-con-
jugated goat anti-rat and anti-rabbit IgG, MitoTracker Deep 
Red FM, CellTracker Orange (CTO), DQ collagen type IV, 
BODIPY (493/503), Hoechst Dye, and Gentamicin (G418) were 
from Invitrogen (Carlsbad, CA, USA). StemXVivo Adipogenic 
Supplement was from R&D Systems (Minneapolis, MN, USA). 
Rosiglitazone was from Cayman Chemical Company (Ann 
Arbor, MI, USA). PureCol collagen type I was from Advanced 
Biomatrix (San Diego, CA, USA). Cultrex™ (rBM; reduced 
growth factor) was from Trevigen (Gaithersburg, MD, USA). Rat 
monoclonal F4/80 was from Abcam (Cambridge, MA, USA). 
Rabbit monoclonal carbonic anhydrase 9 (CA9) and hexokinase 
II (HK2) were from Cell Signaling Technology (Danvers, MA, 
USA). Transwell systems (Costar™ Transwell™ Permeable 
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Supports with 0.4-μm pore size) were from Corning (Corning, 
NY, USA). FABP4 inhibitor (BMS309403) was from Calbiochem 
(San Diego, CA, USA). Atglistatin was from Axon Medchem 
(Groningen, Netherlands).
Cell Lines
PC3, an androgen independent cell line derived from a bone 
metastasis of a high-grade prostate adenocarcinoma, was 
purchased from American Type Culture Collection (ATCC; 
Manassas, VA, USA). The PC3-DsRed cell line was established 
by stable transfection with pDsRed2-N1 vector (Clontech 
Laboratories, Palo Alto, CA, USA), containing the neomycin-
resistant gene. Transfection was performed using Lipofectamine 
2000 and pooled populations of stable cells were selected, 
expanded, and maintained in medium supplemented with 
400 mg/ml of G418 (29). L929 cells (source of M-CSF for mac-
rophages, purchased from ATCC) were cultured until confluent 
and conditioned medium was collected, centrifuged, and stored 
at −80°C until ready for use. PC3 and L929 cells were cultured in 
DMEM supplemented with 10% FBS, 10 mM HEPES, and 100 U/
ml penicillin–streptomycin. All cells were maintained in a 37°C 
humidified incubator ventilated with 5% CO2.
Isolation and Preparation of Primary 
Murine Bone Marrow Adipocytes and 
Macrophages
Collection of murine cells was performed in accordance with the 
protocol approved by the institutional Animal Investigational 
Committee of Wayne State University and NIH guidelines 
(Protocol # 15-12-025; IP, PI). Primary mouse bone marrow stro-
mal cells (mBMSC) were isolated from femurs and tibiae of 6- to 
8-week-old FVB/N mice and induced to become bone marrow 
adipocytes according to our previously published protocols (5). 
Specifically, bone marrow from each tibia and femur was flushed 
with of DMEM containing 20% FBS (4 ml/bone) using a 26-gauge 
needle. Marrow suspension was mixed and broken apart using a 
20-gauge needle and seeded into a 6-well cell culture plate (~3 ml/
well). After 24 h, non-adherent cells were removed by replacing 
the medium. Cells were cultured to confluency by changing the 
medium every 2–3 days and then expanded to larger dishes as 
needed. For adipogenic differentiation, mBMSCs (~600,000/
well) were mixed with bovine collagen I and seeded in six-well 
plates (500  μl/well) for Transwell coculture or 60-mm dishes 
(500 μl, ~1,300,000/dish) for 3D invasion assays. Approximately 
48–72 h later, upon reaching confluency, cells were treated with 
adipogenic cocktail (30% StemXVivo Adipogenic Supplement, 
1  μM insulin, 2  μM Rosiglitazone; DMEM and 10% FBS) for 
8–10 days (5).
For the preparation of bone marrow macrophages (BMMs), 
bone marrow was flushed from femurs and tibiae of 10- to 
12-week-old FVB/N male mice with BMM growth medium 
(MEMα containing 20% FBS and 30% L929-conditioned media 
as the source of M-CSF; 4 ml/bone) using a 26-gauge needle (30). 
The cell suspension was mixed with an additional 20 ml of BMM 
medium using a 20-gauge needle and plated onto three 100-mm 
Petri dishes (12 ml/dish). Cells were cultured for 4–5 days in a 
37°C humidified incubator ventilated with 5% CO2 to obtain 
differentiated BMMs.
2d tumor Cell-Adipocyte Coculture 
Using a transwell system
Bone marrow adipocytes were differentiated in six-well plates as 
described above. On the day of the Transwell setup, tumor cells 
were plated on acid-washed glass coverslips (12 mm in diameter) 
coated with reconstituted basement membrane (rBM; Cultrex™; 
Trevigen). Briefly, 100 μl of 1 mg/ml rBM was added per coverslip 
and allowed to polymerize for 45 min at RT, then the excess was 
removed via suction, and the coverslips were allowed to dry for 
15 min at RT before cells were plated. PC3 cells (30,000–50,000) 
were plated in 500 μl of normal growth medium and allowed to 
settle for a minimum of 4 h at 37°C. Adipocytes were prepared for 
Transwell coculture by washing 3× with PBS and adding 2 ml of 
DMEM supplemented with 5% FBS. Transwell membranes were 
placed above the adipocyte culture according to manufacturer’s 
instructions and coverslips with attached tumor cells (2× cover-
slips per transwell) were placed on each membrane with medium 
gently added on top (2 ml). The control coverslips were cultured 
separately in DMEM supplemented with 5% FBS. All cells were 
allowed to grow for 48 h at 37°C.
3d tumor Cell-Adipocyte Coculture 
Using a transwell system
Adipocytes were prepared as described above for the 2D system. 
The experimental approach to prepare 3D cultures of prostate 
carcinoma cells has been adapted from the original protocols 
for breast cancer progression models developed by the Brugge 
laboratory (31). Non-diluted rBM (15.35 mg/ml) was used for the 
preparation of all cultures. In brief, acid-washed coverslips were 
placed in 35 mm dishes, and 45 μl of rBM was carefully added 
on top of each coverslip, making a continuous surface without 
going over the edge of the coverslip. The dishes were placed in 
37°C for 15 min to polymerize, then 60 μl of PC3 cell suspension 
was placed on top of each rBM-coated coverslip (30,000–35,000 
cells/coverslip). The dishes were placed in a 37°C incubator for 
45 min–1 h to allow the cells to settle and attach to the matrix. 
After cells were attached, 2–3  ml of media (5% FBS, 2% rBM 
overlay) was added to the 35-mm dish control coverslips. For 3D 
Transwell cultures, one 3D coverslip (covering only ~24% of the 
membrane and thus allowing free flow of factors and nutrients) 
was placed on each Transwell membrane positioned above the 
differentiated adipocyte culture, and 2 ml of medium was gen-
tly added (Figure 1). Cells were allowed to grow for 48–120 h 
depending on experimental design.
Immunofluorescence Analyses
For the analysis of the expression and localization of carbonic 
anhydrase 9 (CA9) (Figure 2), control and Transwell coverslips 
from 2D and 3D cultures were washed with PBS, fixed with 
cold methanol, and incubated with rabbit monoclonal anti-CA9 
antibody (1:50) at 4°C overnight. To label the mitochondria, 
coverslips were washed with PBS, and incubated with 200  nM 
MitoTracker Deep Red for 30–45 min at 37°C prior to fixation. 
FIGURe 1 | three-dimensional (3d) culture of prostate tumor spheroids in the absence or presence of bone marrow-derived adipocytes.  
(A) Schematic representation of 3D culture of tumor cells alone plated on reconstituted basement membrane (rBM)-coated coverslips with rBM overlay of 2% rBM 
and cultured alone (left) or in transwell with bone marrow adipocytes (right). (B) 3D reconstruction and DIC (differential interference contrast) images of the middle 
slice depicting morphology of the spheroids of PC3 cells grown for 3 (top) and 5 (bottom) days in control conditions or (C) in transwell coculture with adipocytes. 
40× images; bar, 50 μm; nuclei are labeled with Hoechst dye (blue); green arrow (X), red arrow (Y), and blue arrow (Z) indicate orientation of the spheroid in 3D space. 
(d) Quantification of spheroid volume using Volocity software; data are shown in cubic micrometers and represent the mean (±SD) of three independent experiments 
with at least three independent spheroids measured/experiment; *p < 0.05 and ***p < 0.001 are considered statistically significant.
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For immunodetection of hexokinase 2 (HK2) (Figure  3), cells 
were washed with PBS, fixed with cold methanol, and stained 
with rabbit monoclonal anti-HK2 antibody (1:100) at 4°C 
overnight. Alexa Fluor 488-conjugated goat anti-rabbit IgG 
(1:1000) was used as a secondary antibody for both CA9 and HK2 
immunostaining. For 2D cultures, DAPI was used as a nuclear 
stain, and coverslips were mounted using Vectashield mounting 
medium (Vector Laboratories) before imaging with Zeiss LSM 
510 META NLO confocal microscope using 40× oil immersion 
lens. Coverslips from 3D cultures were left in PBS in 35-mm 
dishes, Hoechst Dye (1:1000) was added for labeling of nuclei, 
and imaging was performed at an extended depth of focus with 
a Zeiss LSM 510 META NLO confocal microscope using a 40× 
dipping lens.
Imaging the Infiltration of Bone Marrow 
Macrophage into 3d tumor spheroids
Primary BMMs were differentiated from murine bone marrow 
cells, as described above. To examine their ability to infiltrate 
the pre-formed tumor spheroids in the absence or presence of 
adipocytes, the 3D tumor-adipocyte Transwell cocultures were 
set up and cultured for 3 days, as described above. To distinguish 
tumor cells from macrophages, PC3 cells were pre-labeled with 
CTO (1:1000 in serum-free media for 1  h at 37°C) prior to 
plating on rBM-covered coverslips. After 3-day culture, medium 
with rBM overlay was removed from the Transwell or control 
dishes, 60  μl of cell suspension containing 150,000 BMMs 
was plated on top of each coverslip and allowed to settle for 
45min-1  h at 37°C, then new medium (containing 2% rBM 
overlay) was reapplied. Cells were allowed to grow for additional 
2 days (Figure 4) before cultures were fixed in 3.7% formalde-
hyde and immunostained for murine macrophage marker F4/80 
using rat anti-mouse F4/80 antibody (1:50). Alexa Fluor 488 
conjugated goat anti-rat IgG (1:1000) was used as a secondary 
antibody. Hoechst Dye (1:1000) was added for labeling of nuclei, 
and imaging was performed at an extended depth of focus with 
Zeiss LSM 510 META NLO confocal microscope using a 40× 
dipping lens.
Imaging Proteolysis by Live Prostate 
tumor Cells in the Absence or Presence 
of Infiltrating BMMs
Cleavage of DQ-collagen IV substrate by live PC3 cells 
grown in a control or Transwell coculture with adipocytes 
FIGURe 2 | expression of carbonic anhydrase 9 (CA9) in 2d and 3d cultures of PC3 cells grown alone or in transwell coculture with adipocytes. 
Immunofluorescence analysis of CA9 expression (green) in monolayer PC3 cultures grown alone (A) or in transwell with adipocytes (B). (C) 2D no primary CA9 
antibody control; DAPI was used as nuclear marker (Blue). 3D reconstruction of CA9 expression in tumor spheroids grown alone (d) or in transwell with adipocytes 
(e); green arrow (X), red arrow (Y), and blue arrow (Z) indicate orientation of the spheroid in 3D space. Middle slice through z-stack showing CA9 expression in 
spheroids cultured alone (F,G,J,K) or in transwell with adipocytes (h,I,L,M). Hoechst dye was used for labeling nuclei [(F,h); blue], CA9 [(G,I); green], DIC [(J,L); 
differential interference contrast], and merged images (K,M). (N) 3D culture; no CA9 primary antibody control; 40× images; bar, 50 μm.
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in the presence or absence of BMMs was assayed in real 
time and quantified based on published protocols (32–34). 
Briefly, single cell suspensions of tumor cells (30,000–35,000) 
were plated on top of coverslips coated with rBM containing 
DQ-collagen IV (1:30) and overlayed with 2% rBM. Cells 
were grown alone or in Transwell coculture with adipocytes 
for 3 days prior to addition of pre-labeled BMMs (Figure 5). 
After an additional 2-day culture, Hoechst dye was added 
as nuclear marker and DQ-IV proteolysis under all culture 
conditions was imaged live at an extended depth of focus 
with Zeiss LSM 510 META NLO confocal microscope using 
a 40× dipping lens.
Coculture of Bone Marrow 
Macrophages with Prostate tumor  
Cells in a 3d transwell system
To examine the effects of BMMs on 3D growth and proteolysis 
by prostate tumor cells cocultured with marrow adipocytes, we 
pre-labeled differentiated BMMs by incubating them with a 
FIGURe 3 | hexokinase 2 (hK2) expression and in 2d and 3d cultures of PC3 cells grown alone or in transwell coculture with adipocytes. Expression 
of HK2 [(A), green] and MitoTracker [(B), red] merged (C) in PC3 cells grown alone (A–C) or in transwell (e–G) in 2D coculture. (d,h) No HK2 primary antibody 
controls; DAPI was used as nuclear marker (blue). (I,J) 3D reconstruction of CA9 expression in tumor spheroids grown alone (I) or in transwell with adipocytes (J); 
green arrow (X), red arrow (Y), and blue arrow (Z) indicate orientation of the spheroid in 3D space. HK2 and MitoTracker fluorescence to show HK2 localization to the 
mitochondria in PC3 cells cultured alone (K–N) or in Transwell with adipocytes (P–s). (o,t) No HK2 primary antibody controls; 40× images; bar, 50 μm.
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1:1000 dilution of with CellTracker Orange (CTO) in serum-free 
medium for 1 h at 37°C. Labeled BMMs were then washed 3× with 
PBS and maintained in normal BMM medium overnight until 
use. On the day of 3D Transwell setup, adipocytes and prostate 
tumor cells were prepared as described above. Coverslips were 
coated with rBM and 75,000 BMMs mixed with 30,000 PC3 cells 
were plated together on top of a coated coverslip, as described 
above. As before, one 3D coverslip was placed on each Transwell 
membrane positioned above differentiated adipocyte culture, 
and 2  ml of medium was gently added (Figure  6). Cells were 
allowed to grow for 3 days, and DQ-IV proteolysis was imaged 
live at an extended depth of focus with a Zeiss LSM 510 META 
NLO confocal microscope using a 40× dipping lens.
3d Invasion Assays
Bone marrow-derived mBMSC cells were mixed with col-
lagen I matrix and plated in 60-mm dishes (500  μl/dish; 
~1,300,000/500  μl). Cells were differentiated into adipocytes 
over the course of 8–10  days as described above. Post-
differentiation, each plate was washed 3× with PBS, with all 
PBS carefully removed before 1 ml of collagen I was added on 
top and allowed to polymerize at 37°C for 45 min–1 h. A total 
FIGURe 4 | Infiltration of bone marrow macrophages (BMMs) into 3d cultures of PC3 cells exposed to adipocytes. (A) Schematic representation of 
experimental design. 3D cultures were grown alone or in transwell coculture with adipocytes for three days prior to addition of bone marrow macrophages and 
culture for an additional 2 days. (B,C) 3D reconstruction of tumor spheroids infiltrated with BMMs in the absence (B) or presence of adipocytes (C); F4/80: 
macrophage marker (green); CellTracker Orange: PC3 cell label (red); Hoechst: nuclear label (blue); green arrow (X), red arrow (Y), and blue arrow (Z) indicate 
orientation of the spheroid in 3D space. Middle slice through z-stack showing F4/80, cell tracker, and Hoechst staining of PC3 spheroids with or without BMMs 
grown in control conditions (d,e) or in transwell with adipocytes (F,G); 40× images; bar, 50 μm
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of 4 ml of medium, containing 400,000 dsRed-expressing PC3 
cells, was gently added on top. Cultures were maintained in a 
37°C humidified incubator ventilated with 5% CO2 for up to 
96 h. At designated time-points, plates were washed with PBS, 
fixed for 45  min with 3.7% formaldehyde at RT, stained with 
BODIPY (493/503) (1:1000, 1  h at RT), nuclei were marked 
with Hoechst dye, and imaged at an extended depth of focus 
with a Zeiss LSM 510 META NLO confocal microscope using 
a 20× dipping lens (Figure 7). For inhibitor studies (Figure 8), 
FABP4 inhibitor (BMS309403; 1 μM) and Atglistatin (10 μM) 
were added to both the collagen I layer between the adipocytes 
and the tumor cells as well as the medium, and were replenished 
in the medium daily.
Image Reconstruction and Fluorescence 
Quantification
All images were captured using a Zeiss LSM510 META NLO 
confocal microscope (Carl Zeiss AG, Göttingen, Germany). For 
2D cultures, a 40× oil immersion lens was used, and a single 
slice was captured. 3D cultures were imaged in 35 mm dishes 
with a 40× water immersion lens, and z-stacks of 2–4 μm optical 
FIGURe 5 | Live proteolysis by 3d prostate tumor cell cultures in the absence or presence of infiltrating macrophages. (A) Schematic representation of 
experimental design. 3D cultures were seeded on rBM containing DQ-Collagen IV substrate and grown alone or in transwell coculture with adipocytes for 3 days 
prior to addition of bone marrow macrophages and culture for an additional 2 days. (B–e) 3D reconstruction of DQIV proteolysis by tumor spheroids cultured alone 
(B) or infiltrated with BMMs (C) in the absence or presence of adipocytes (d,e); DQ-Collagen IV cleavage products (green), CellTracker Orange: PC3 cell label (red); 
Hoechst: nuclear label (blue); green arrow (X), red arrow (Y), and blue arrow (Z) indicate orientation of the spheroid in 3D space. (F–I) Middle slice through z-stack 
showing DQIV fluorescence, CellTracker Orange, and Hoechst staining of PC3 spheroids with or without BMMs grown in control conditions (F,G) or in transwell with 
adipocytes (h,I); 40× images; bar, 50 μm. (J) Quantification of DQ-Collagen IV proteolysis shown as fluorescence intensity per cell in the entire volume; nuclei were 
stained with Hoechst 33342 (blue) at the time of imaging and counted. Data are shown as average (±SD) of three independent experiments with at least three 
independent spheroids measured/experiment.
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slices were captured. 3D reconstruction of optical slices was 
performed using Volocity software (PerkinElmer, Waltham, 
MA, USA). For quantification of DQ-IV proteolysis, Volocity 
software was used to determine integrated intensity per image 
by dividing the total sum of green fluorescence signal (thresh-
olded using intensity) by the number of nuclei in the image. At 
least three replicates were measured per condition. The totals in 
each group were averaged and shown as mean ± SEM.
Measurement and Quantification 
of Invasion
Invasion cultures in 60  mm dishes were imaged using a 20× 
water immersion lens, and z-stacks of 4  μm increments were 
captured. 3D reconstruction of optical slices was performed using 
Volocity software. For quantification of distance traveled by the 
tumor cells, images were opened in Zeiss LSM Image Browser. 
After removing the DIC channel, the Ortho tool was used to 
select and measure the distance from the middle of PC3 (red) 
layer to the middle of the adipocyte (green) layer. Distances 
between PC3 and adipocyte layers were recorded from at least 
three biological triplicates. For inhibitor studies, distances were 
shown as percent of distance at baseline (4-h control).
statistical Analyses
All data analyses were performed using GraphPad Prism Software 
version 6.05. Data were presented as mean ± SD and statistically 
analyzed using unpaired Student’s t-test. For three or more 
groups, one-way analysis of variance was used.
ResULts
three-dimensional Culture of Prostate 
tumor spheroids in the Absence or 
Presence of Bone Marrow-derived 
Adipocytes
Adipocytes are metabolically active cells that have been shown 
to promote growth and aggressiveness of several cancers, par-
ticularly those that grow in adipocyte-rich microenvironments 
FIGURe 6 | Contribution of bone marrow macrophages to proteolysis of dQ-Collagen IV by tumor cells exposed to bone marrow adipocytes. (A) 
Schematic representation of experimental design. Tumor cells were mixed with BMMs, and 3D cultures were seeded on rBM containing DQ-Collagen IV substrate 
and grown alone or in transwell coculture with adipocytes for 3 days. (B–e) 3D reconstruction of DQIV proteolysis by tumor spheroids seeded alone (B) or with BMMs 
(C) in the absence or presence of adipocytes (d,e); DQ-Collagen IV cleavage products (green), CellTracker Orange: PC3 cell label (red); Hoechst: nuclear label (blue); 
green arrow (X), red arrow (Y), and blue arrow (Z) indicate orientation of the spheroid in 3D space. (F–I) Middle slice through z-stack showing DQIV fluorescence, 
CellTracker Orange, and Hoechst staining of PC3 spheroids with or without BMMs grown in control conditions (F,G) or in transwell with adipocytes (h,I); 40× images; 
bar, 50 μm. (J) Quantification of DQ-Collagen IV proteolysis, quantified in each 3D reconstructed spheroid using Volocity Software, is shown as fluorescence intensity 
per cell in the entire volume; nuclei were stained with Hoechst 33342 (blue) at the time of imaging and counted. Data are shown as average (±SD) of three 
independent experiments with at least three independent spheroids measured/experiment. *p < 0.05 and ***p < 0.001 are considered statistically significant.
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such as the breast or ovary (10, 35, 36). The fat cells resid-
ing specifically in the bone marrow have been increasingly 
credited with the ability to support and promote metastatic 
growth in bone (4–9). We have shown previously that exposure 
of prostate tumor cells to marrow adipocyte-supplied factors 
increases their proliferation and invasiveness (5). Here, to 
better mimic physiological conditions and to allow explora-
tion of molecular mechanisms of adipocyte involvement in 
metastatic tumor growth in bone, we developed a cell culture 
model that allows 3D growth of prostate cancer cells exposed 
to adipocytes.
Seeding of the single-cell suspensions of PC3 prostate car-
cinoma cells on rBM-coated coverslips with 2% rBM overlay 
results in a formation of tumor spheroids (Figure  1). Cells 
cultured in their normal growth medium (CONTROL) form 
compacted, rounded spheroids after 3-day culture (Figure 1B, 
top panels). In contrast, tumor cells grown in a Transwell 
coculture with marrow adipocytes (TRANSWELL) form much 
larger and more disorganized clusters (Figure 1C, top panels). 
Longer, 5-day culture of PC3 cells results in further growth 
under either of the conditions, with Transwell cultures exhibit-
ing significantly more robust proliferation and acquiring much 
more disordered morphology compared with control cultures 
(Figures 1B,C, bottom panels). Quantification of 3D volumes 
of the spheroids confirms the growth-promoting effects of 
adipocytes on tumor cells and indicates potential utility of this 
experimental system for interrogation of adipocyte–tumor cell 
interactions (Figure 1D).
Modeling Metabolic Responses  
to Marrow Adipocytes
One way that adipocytes can affect tumor cell behavior is by 
regulating cancer cell metabolism (37). Adipocyte-supplied lipids 
have been shown to feed into the glycolytic pathway and (38–40) 
and induce the Warburg effect in tumor cells (41–45). One of the 
master regulators of metabolic reprograming is hypoxia inducible 
factor (HIF), a key driver of hypoxic stress (46). Bone marrow 
adipocytes have a capability of inducing HIF-1α signaling in 
prostate tumor cells grown in 2D monolayer culture (Podgorski 
FIGURe 7 | three-dimensional invasion of tumor cells toward bone marrow adipocytes. (A) Diagram depicting the experimental setup. Tumor cells invaded 
through collagen I matrix toward bone marrow adipocytes. Adipocytes (BODIPY, green); Tumor cells (DsRed; red) for 4 h (B), 22 h (C), 46 h (d), and 96 h (e) and 
decreasing distance between the tumor cells and adipocytes over time is shown in micrometers. Green arrow (X), red arrow (Y), and blue arrow (Z) indicate 
orientation of the spheroid in 3D space.
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et  al., unpublished results1). It is, however, well-recognized 
that tissue dimensionality and associated oxygen status have a 
potential to profoundly affect hypoxic response in tumor cells 
(19, 47). Therefore, we examined the utility of our 3D Transwell 
model to measure hypoxia response to adipocytes. Our 3D 
cultures established on glass coverslips are  easily fixable and 
suitable for immunocytochemical analyses. We used carbonic 
anhydrase 9 (CA9), a HIF-1α target gene (48), as a measure 
of hypoxic response in our system. The immunofluorescence 
analysis of CA9 protein revealed a significant increase and 
typical membrane localization in 2D tumor cell cultures exposed 
to adipocytes (Figures  2A,B), indicating activation of HIF-1α 
signaling. Interestingly, cells grown in 3D culture showed robust 
CA9 expression even under control conditions (Figure  2D). 
However, although tumor cells grown in transwell coculture with 
adipocytes expectedly formed significantly larger, disorganized 
structures (Figures 2E,H,I,L,M), there was no visible increase in 
CA9 expression compared with spheroids grown under control 
conditions (Figures  2D,F,G,J,K). This was further confirmed 
by the quantification of CA9 fluorescence/nuclei in each of the 
3D structures (data not shown). 3D growth alone appears to 
activate HIF-1α signaling, which is consistent with the reports 
of heterogeneous oxygen distribution in 3D cultures (47). This 
1 Diedrich J, Rajagurubandara E, Herroon MK, Mahapatra G, Huttemann M, 
Podgorski I (unpublished results).
speaks to the importance of considering tissue architecture while 
examining metabolic responses within the tumor microenviron-
ment. Further studies are underway to validate these findings.
One important consequence of HIF-1α activation is the 
induction of glycolytic phenotype in tumor cells. We performed 
immunofluorescence analysis of expression and localization of 
hexokinase-2 (HK2), a critical enzyme in the first step of glycoly-
sis, that elicits its functions by binding to the voltage-dependent 
anion channels (VDAC) in the outer mitochondrial membrane 
(49, 50). Low HK2 expression was detected in monolayer cultures 
of PC3 cells (Figure 3A), with robust increases in HK2 fluores-
cence upon exposure to adipocytes (Figure 3E). This is consistent 
with adipocyte-induced Warburg phenotype in these cells (see 
footnote text 1). Mitotracker labeling (Figures  3B–D,F–H) 
showed no observable differences in the number of mitochondria 
between the control and Transwell conditions. The majority of the 
HK2 appeared to co-localize with mitochondria (Figures 3C,G), 
which is consistent with the literature evidence demonstrating 
that approximately 80% of total HK2 is bound to the mitochon-
drial VDAC (51).
In stark contrast to the monolayer cultures, a significant HK2 
expression was observed in PC3 3D spheroids even under control 
conditions (Figures 3I,K–N). This indicates a potential enhance-
ment of glycolytic phenotype, consistent with activation of HIF-
1α signaling by 3D culture (Figure 2). High HK2 fluorescence 
closely mirroring mitochondrial pattern was also observed in 
3D cultures grown under Transwell conditions (Figures 3J,P–S). 
FIGURe 8 | Inhibition of tumor cell invasion toward adipocytes with FABP4 inhibitor and Atglistatin. (A,B) Invasion under control conditions at 4 h (A) and 
70 h (B). Adipocytes (BODIPY, green); Tumor cells (DsRed; red). (C) Invasion in the presence of 10 μM Atglistatin, (d) 1 μM FABP4 inhibitor, (e) Invasion in the 
presence of FABP4 inhibitor and Atglistatin in combination. Green arrow (X), red arrow (Y), and blue arrow (Z) indicate orientation of the spheroid in 3D space (F) 
Quantification of the average distance between PC3 cells and adipocytes under all experimental conditions. Distances between PC3 and adipocyte layer 
(in micrometers) were measured using the Zeiss LSM Image Browser software. Data were analyzed using GraphPad Prizm and shown as the mean of three 
independent experiments ± SD (relative to baseline invasion at 4 h). *p < 0.05 and ***p < 0.001 are considered statistically significant.
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However, HK2 fluorescence intensity was not significantly higher 
than in control cultures, indicating no significant enhancement 
of HK2 levels by coculture with adipocytes (data not shown).
examining effects of Marrow Adipocyte 
Presence on tumor Response to Bone 
Marrow Macrophages
Bone represents a complex, dynamic microenvironment and 
establishment of metastatic lesions in the skeleton requires 
tumor cell interactions with a number of cell types in the 
marrow. To examine the suitability of our cell culture system 
to study multi-cell interactions, we incorporated BMMs into 
3D tumor spheroids growing under control and Transwell 
conditions (Figure  4A). Pre-labeling of PC3 tumor cells with 
CTO allowed visualization of the tumor growing in 3D culture 
(Figures  4B,C). We tracked the incorporation of BMMs into 
the tumor spheroid by F4/80 immunofluorescence staining. 
Tumors growing under Transwell conditions with adipocytes 
attracted more macrophages than those cultured under control 
conditions (Figures  4B,C; green fluorescence). Incorporation 
of BMMs into the spheroid was also visible in the optical 
slices taken in the middle of the spheroid (Figures  4D–G). 
These observations suggest that adipocytes might be inducing 
phenotypic changes in the tumor cells and/or macrophages to 
promote the BMM affinity for the tumor. Further studies are 
needed to confirm this hypothesis.
Imaging Live tumor Cell-driven 
Proteolysis in the Presence of Marrow 
Adipocytes
To grow and thrive in their surrounding environments, tumors 
have to interact with the extracellular matrix (ECM) via bio-
chemical and mechanical processes. Proteolysis of the ECM is 
one of the key aspects of tumor invasion (52, 53), and we have 
previously shown that exposure to adipocyte-derived factors 
increases invasive potential of prostate carcinoma cells (5). One 
way to effectively visualize ECM proteolysis by the tumor cells 
and other cell types residing in the tumor microenvironment 
is through a confocal microscopy assay utilizing quenched-
fluorescent (DQ) proteins, an approach developed by the Sloane 
laboratory over a decade ago (53). We have previously utilized 
this technique to demonstrate that prostate carcinoma cells are 
capable of degrading quenched fluorescent derivatives of col-
lagen IV (basement membrane) and collagen I (organic matrix 
of the bone) (33). Therefore, we used this approach to determine 
whether exposure to adipocyte-derived factors affects the col-
lagen IV degradation in our model. PC3 cells plated on rBM 
containing DQ-IV were allowed to establish into spheroids 
by growing for 3  days under control or Transwell conditions 
before adding CTO-labeled BMMs and allowing cultures to 
continue for additional 2 days (Figure 5A). Degradation of the 
DQ-collagen IV, observed as green fluorescence, was captured 
and quantified at the end of 5-day culture. In agreement with 
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our previous findings (33), fluorescent cleavage products 
of DQ-collagen IV were found both intracellularly and 
pericellularly (Figures  5B–E). Similar levels of fluorescence 
were detected in PC3 cells cultured alone (without BMMs) 
regardless if they were under control or Transwell conditions 
(Figures  5B,D,F,H,J), suggesting no measurable contribution 
of adipocytes to tumor-driven proteolysis.
Since macrophages are important sources of proteases and 
key contributors to tumor-associated proteolysis (34, 53), we 
also measured and quantified the DQ-IV fluorescence following 
the 2-day coculture of pre-established tumor spheroids exposed 
to macrophages (Figures  5C,E,G,I,J). Surprisingly, despite the 
significant infiltration of BMMs into tumor spheroids exposed to 
adipocytes in a Transwell coculture and visible BMM-associated 
proteolysis (Figures  5E,I), there was no significant increase in 
overall tumor-associated DQ-IV degradation compared with 
cultures grown without macrophages (Figure 5J).
Interestingly, when macrophages were incorporated into the 
culture at the time of seeding the tumor cells (Figure 6A), signifi-
cant changes were observed in the morphology of the resulting 
spheroids and in the tumor-associated proteolysis. Specifically, 
under control conditions, addition of BMMs led to formation 
of less compacted and more disorganized tumor spheroids 
compared with tumor cells cultured alone (Figures  6B,F vs. 
Figures 6C,G). This change in morphology was also associated 
with a significant increase in DQ-IV proteolysis (Figure 6J). Even 
more pronounced effects of BMMs were observed in cultures 
exposed to adipocytes in the Transwell system (Figure  6D,H 
vs. Figures 6E,I). Formation of highly disorganized tumor cell/
BMM clusters with high levels of DQ-IV fluorescence (Figure 6J) 
suggested potentially important contribution of adipocytes to 
tumor- and BMM-driven proteolytic activity in this model.
Quantifying tumor Cell Invasion toward 
Adipocytes in three-dimensional system
Our previous work has shown that prostate carcinoma cells 
exposed to media conditioned by marrow adipocytes take up 
the fat cell-supplied lipids in a process that results in accelerated 
tumor growth and invasiveness (5). Prostate tumor cells have 
been reported to be attracted to adipocyte-rich areas of the 
bone marrow, where metastases commonly occur (54, 55), and 
the translocation of adipocyte-stored lipids has been linked to 
increased tumor cell motility (56). The mechanisms behind the 
tumor cell attraction to marrow fat cells, however, remain poorly 
understood. Here, we have designed a simple 3D system in which 
tumor cell invasion toward adipocytes can be easily visualized, 
measured, and quantified (Figure  7A). We used collagen I, 
the predominant component of bone, as the matrix separating 
BODIPY-labeled bone marrow adipocytes (bottom) and DsRed-
expressing PC3 cells (top). Tumor cells invaded through collagen 
I matrix over the course of 96 h (Figures 7B–E), with complete 
merging of the two cell types at the 96-h time point.
We next tested two compounds with potential to affect adipo-
cyte–tumor cell interactions: a selective inhibitor of fatty acid-
binding protein 4 (FABP4) (BMS309403) (5), and Atglistatin, 
a selective inhibitor of Adipocyte Triglyceride LIpase (ATGL) 
(57). We chose to inhibit FABP4 based on our previous studies 
demonstrating upregulation of this lipid transporter in prostate 
tumor cells exposed to marrow adipocytes, and the apparent effi-
cacy of BMS309403 in inhibiting prostate tumor cell invasion in 
the 2D Boyden chamber assay (5). We also used Atglistatin as the 
means of inhibiting adipocyte-driven lipolysis, which we have 
shown to be induced by prostate tumor cells (see footnote text 
1). As expected, under control conditions, the distance between 
PC3 cells and marrow adipocytes was significantly reduced 
after 70 h, compared with the baseline at 4 h (Figures 8A,B). 
Atglistatin alone did not seem to have any effect on tumor cell 
invasion toward the adipocytes (Figure  8C). Despite potent 
inhibition of PC3 invasion in 2D (5), only modest inhibition of 
tumor invasion was observed with FABP4 inhibitor in a 3D assay 
(Figure  8D), a result potentially due to differences in matrix 
and experimental conditions between the two assays. Notably, 
however, the use of both inhibitors in combination significantly 
inhibited tumor invasion and restored the distance between 
the two cell types to the levels measured at 4 h (Figures 8E,F). 
This suggests a potential link between lipid hydrolysis and 
transport between adipocytes and tumor cells that needs further 
investigation.
dIsCUssIoN
The functional role of bone marrow adipocytes in the growth 
and aggressiveness of skeletal tumors is an understudied and not 
well-understood area of cancer research. There is a great need for 
in vitro 3D models that can address the complexity of the bone 
tumor microenvironment, yet allow dissection of the mechanisms 
behind the contribution of specific cell types to the metastatic 
growth. There has been a growing effort to generate 3D models 
that would represent a bridge between the 2D monolayer cultures 
and in vivo tumor microenvironment, with the idea of capturing 
the physiological complexity, multiplicity of cell types, ECM com-
position, and temporal and spatial distribution of soluble factors 
in the bone microenvironment (21, 28, 58–61). Many of these 
models have been key to demonstrating the importance of 3D 
tumor architecture in mechanistic understanding of basic cancer 
biology and, especially, in evaluating tumor response to therapy 
(22, 58, 61). Regretfully, however, none of these models to date 
have addressed the contribution of fat cells, one of most abundant 
cell types in the adult bone marrow to growth, phenotype, and 
behavior of metastatic tumor cells in bone.
The in vitro approaches we describe herein provide a simple 
way of examining interactions between bone marrow adipo-
cytes and metastatic tumor cells in a physiologically relevant 
manner. Our Transwell system combines 3D culture of bone 
marrow-derived adipocytes with 3D culture of prostate tumor 
cells to allow paracrine interactions and sharing of nutrients and 
secreted factors by the two cell types. We show via immunofluo-
rescence analysis of metabolism-associated proteins that under 
3D conditions tumor cells have significantly different metabolic 
responses to adipocytes than tumor cells grown in a monolayer 
culture. This underlines the importance of employing 3D culture 
conditions to mimic physiological interactions between marrow 
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adipocytes and metastatic tumor cells. It is noteworthy that the 
simple design of our 3D system allows easy manipulation, pro-
cessing, and analysis of the resulting cultures. Because tumor cell 
cultures are established on glass coverslips they are immediately 
available for immunocytochemistry and confocal imaging. These 
samples can also be recovered from the coverslips and processed 
for protein and RNA analyses (data not shown), allowing for 
additional data to support the confocal imaging results. We have 
also shown the suitability of this system to image proteolysis 
by living cells. We used DQ Collagen IV as a representative 
component of the basement membrane, but this approach can 
be easily modified for use with other DQ-labeled matrices, such 
as DQ Collagen I [a major protein in the bone (33, 62)], or with 
activity-based probes (63).
Contribution of other bone marrow-derived cell types is an 
important consideration in the design of physiologically relevant 
cell culture models. Our data show that BMMs can be easily 
incorporated into our coculture system. More importantly, we 
reveal that macrophages are attracted to tumor spheroids exposed 
to adipocyte-derived factors, and their coculture with tumor cells 
results in a more aggressive morphology and an enhanced ECM 
proteolysis by both cell types. This speaks to the importance 
of multi-cellular design in modeling the effects of specific cell 
types on tumor phenotype and behavior. Our system allows the 
manipulation of the design to vary cell types, numbers, and ECM 
components. Studies are currently ongoing to examine the effects 
of direct interaction of marrow macrophages with adipocytes on 
tumor cell growth and aggressiveness.
Previous studies have indicated that prostate tumor cells are 
attracted to adipocyte-rich areas in the bone marrow (54, 55). 
Our 3D invasion assay results confirm this attraction and provide 
a simple approach to evaluate potential targets involved in this 
process. We utilized our invasion system to inhibit the lipid trans-
porter FABP4, and the main adipocyte lipase ATGL and revealed 
that ATGL-driven lipolysis and FABP4-driven lipid transport 
might be important for tumor cell–adipocyte interaction in 
the bone marrow microenvironment. This not only opens new 
avenues for investigation but also speaks to the potential utility 
of this assay as an initial screen to identify factors behind tumor 
cell invasiveness toward the marrow adipocytes. Many G protein-
coupled receptors (GPRCs), including chemokine receptors and 
receptors of bioactive lipids, have been implicated in tumor cell 
growth and invasiveness (64). Given the fact that adipocytes 
are an abundant source of chemokines and lipids, their role in 
modulating the invasive capacity of tumor cells via GPCRs could 
be studied in this system. It is also important to mention that this 
approach is easily modifiable in terms of matrix type and thick-
ness, time of invasion and cell types used, representing a useful 
tool to examine the functional effects of marrow adipocytes on 
tumor cell invasiveness.
We acknowledge that our models have limitations. First, we are 
utilizing adipocytes differentiated from bone marrow mesenchy-
mal cells, which may not be entirely representative of adipocyte 
population in bone. Emerging data now show that there might be 
differences in bone marrow fat depending on localization in the 
bone (17), and we would not be able to capture these differences 
with our model. Second, we are utilizing murine bone marrow 
cells in combination with human tumor cells, which may not be 
entirely clinically relevant. Species-specific osteotropism is an 
important factor to be considered in design of physiologically 
relevant models (65). This would be particularly important when 
utilizing this model to study the effects of adipocyte-derived 
cytokines and chemokines on tumor cells. Adipokines, such 
as hepatocyte growth factor (HGF) or interleukin-6 (IL-6) are 
known to activate their receptors in a species-specific manner 
(66, 67). Nevertheless, it is important to mention that murine 
cells in our system can be easily replaced with human derived 
mesenchymal bone marrow cells to eliminate this issue.
Our model does not entirely recapitulate the bone tumor 
microenvironment found in the patient with metastatic disease, 
but it provides a controllable, testable system for examination 
of the molecular mechanisms behind adipocyte involvement in 
tumor progression in bone. We believe that the models described 
herein provide a good compromise between currently utilized 2D 
adipocyte-tumor cell cocultures and in vivo mouse models, where 
dissection of the specific contribution of adipocytes is not pos-
sible. Further development of these in vitro culture systems and 
combining them with other bone metastasis-focused cell culture 
models will open new strategies to increase our understanding 
of the role of marrow adipose tissue in metastatic progression.
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